Skip to main content
Erez N. Baruch on Muck Rack

Erez N. Baruch

As seen in: Nature, Memory Studies, Science Magazine, Cell Press, Texas Medical Center, European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Erez N.

Contact Erez N., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Dietary sulfur amino acids enhance anti-tumor immunity in colon cancer via an NKT cell-XCL1-cDC1 circuit

|
By Lior Lobel, Diogo Fonseca-Pereira, Geicho Nakatsu, Monia Michaud, Y. Cao, Sena Bae, Cathleen Krabak, Yaara Oren, Slater L. Clay, Geniver El Tekle, Eunyoung Chun, Shigeyuki Kon, Andrew Chan, Jon Clardy, Jonathan N. Glickman, Nadim J. Ajami, Abderrahman Day, Ashish Damania, Erez N. Baruch, Michael White Verified, Laurence P Diggs, Jennifer Wargo, Thomas Riffelmacher, Ann Balancio, Mitchell Kronenberg, Curtis Huttenhower, Wendy S. Garrett
| Cell Press Verified
Keywords colon cancer anti-tumor immunity mucus microbiome Mucispirillum schaedleri XCL1 cDC1 sulfur amino acids NKT Get full text access Log in, subscribe or purchase for full access. References 1. Siegel, R.L. ∙ Wagle, N.S. ∙ Cercek, A. ... Colorectal cancer statistics, 2023 CA Cancer J. Clin. 2023; 73:233-254 2. Topalian, S.L. ∙ Drake, C.G. ∙ Pardoll, D.M. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy Cancer Cell. 2015; 27:450-461 3. Ciardiello, D.
Open in Who Shared Issue with article?

Cultivating the microbiome to enhance cancer immunotherapy

|
By Erez N. Baruch, Nadim J. Ajami, Jennifer Wargo
| Nature Verified
Three recently published studies demonstrate the feasibility of modulating gut microorganisms using faecal microbiota transplantation (FMT) in patients receiving immune-checkpoint inhibitors (ICIs) in the first-line setting, expanding the evidence that FMT can augment response to ICIs. Herein, we discuss several opportunities for refining these efforts in order to increase the rigour and clinical benefit from microbiota modulation trials in oncology.
Open in Who Shared Issue with article?

Cancer-Induced Nerve Injury Promotes Resistance to Anti-PD-1 Therapy

|
By Erez N. Baruch
| Texas Medical Center
10.1038/s41586-025-09370-8 Post-print Animals, Programmed Cell Death 1 Receptor, Mice, Humans, Drug Resistance, Neoplasm, Female, Male, Interleukin-6, Melanoma, Interferon Type I, Tumor Microenvironment, Receptor, Interferon alpha-beta, Stomach Neoplasms, Skin Neoplasms, Peripheral Nerve Injuries, Carcinoma, Squamous Cell, Inflammation, Signal Transduction, Immune Checkpoint Inhibitors, Neurons, Neoplasms, Neoplasm Invasiveness, Tumour immunology, Cancer microenvironment, Immunotherapy,...
Open in Who Shared Issue with article?
See all 11 articles